BIIB

Biogen Inc. Press Releases

$303.69
*  
0.80
0.26%
Get BIIB Alerts
*Delayed - data as of Aug. 28, 2015  -  Find a broker to begin trading BIIB now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Biogen Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
8/26/2015 12:35:00 PM - Business Wire
▲6.49 % Price Change since this news event. The Volume Ratio is 0.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Biogen, the ALS Association and Columbia University Medical Center Collaborate to Drive Understanding of Genetic Influence in ALS
8/18/2015 7:00:00 AM - Business Wire
▼-3.93 % Price Change since this news event. The Volume Ratio is 0.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of ALPROLIX for the Treatment of Hemophilia B
8/17/2015 7:00:00 AM - Business Wire
▼-2.66 % Price Change since this news event. The Volume Ratio is 0.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate® Published in Haemophilia
8/10/2015 7:00:00 AM - Business Wire
▼-1.72 % Price Change since this news event. The Volume Ratio is 0.83.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BetterInvesting Magazine Releases October Stock To Study And Undervalued Stock Choices For Investors'' Informational And Educational Use
8/7/2015 4:05:00 PM - PR Newswire
▼-1.72 % Price Change since this news event. The Volume Ratio is 0.83.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Flex Pharma Reports Second Quarter 2015 Financial Results
8/5/2015 7:30:00 AM - Business Wire




Biogen Enters Collaboration with the Parkinson’s Institute and Clinical Center
7/27/2015 7:30:00 AM - Business Wire
▼-0.10 % Price Change since this news event. The Volume Ratio is 2.27.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Second Quarter 2015 Revenues Increase 7% to $2.6 Billion
7/24/2015 6:50:00 AM - Business Wire
▼-22.92 % Price Change since this news event. The Volume Ratio is 11.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Presents New Data from Phase 1B Study of Investigational Alzheimer’s Disease Treatment Aducanumab (BIIB037) at Alzheimer’s Association International Conference® 2015
7/22/2015 6:45:00 AM - Business Wire
▼-26.02 % Price Change since this news event. The Volume Ratio is 2.79.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Garmin® Introduces Sport PRO™ Remote Trainer
7/20/2015 7:00:00 AM - Business Wire




Douglas Williams to Leave Biogen for Biotechnology Start-Up
7/10/2015 11:35:00 AM - Business Wire
▼-21.75 % Price Change since this news event. The Volume Ratio is 3.62.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Biogen to Report Second Quarter 2015 Financial Results on July 24, 2015
7/6/2015 4:01:00 PM - Business Wire
▼-24.95 % Price Change since this news event. The Volume Ratio is 1.62.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Biogen and AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology
7/2/2015 7:00:00 AM - Business Wire
▼-25.09 % Price Change since this news event. The Volume Ratio is 1.16.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Invests in the Greater Zurich Area: Biopharmaceutical Plant in the Canton of Solothurn Planned
7/1/2015 7:15:00 AM - PR Newswire
▼-24.82 % Price Change since this news event. The Volume Ratio is 1.44.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen and Sobi Announce European Medicines Agency Validates ALPROLIX® (rFIXFc) Marketing Authorization Application
6/26/2015 2:00:00 AM - Business Wire
▼-26.16 % Price Change since this news event. The Volume Ratio is 0.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Achieves Carbon Neutrality
6/23/2015 12:30:00 PM - Business Wire